Press Release | 11.15.18 PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy on Virus-Based Gene Therapy to Treat Solid Tumors
Research Update | 11.09.18 Could probiotics reduce immunotherapy’s chances of working in cancer patients?
Press Release | 10.18.18 The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
Announcement, Research Update | 10.01.18 James Allison, Parker Institute for Cancer Immunotherapy Director, Wins 2018 Nobel Prize in Medicine or Physiology for Research on Immune Checkpoint Inhibitors
Announcement, Research Update | 09.25.18 Parker Institute Researchers Featured at Fourth International Immunotherapy Conference 2018 in New York #CICON18
Partner Highlight | 08.14.18 Novel Approaches for Better Patient Responses with Immunotherapy: Seres Therapeutics
Research Update | 07.12.18 PICI Scientist at Dana-Farber Cancer Institute Unravels Structure of Key Cancer Detection Protein in Immune System